Cabozantinib tolerability in metastatic renal cell carcinoma: A meta-analysis. Tislelizumab combined with gemcitabine and cisplatin (GC) as adjuvant therapy in patients with high-risk upper urothelial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results